Boston Life Sciences Inc
Permanently closed
20 Newbury St Ste 5
Boston, MA 02116
Boston Life Sciences Inc is a biotechnology company based in Boston, MA, focused on the research and clinical development of innovative diagnostic and therapeutic products targeting central nervous system diseases. The company has recently made significant strides, including electing William L. S. Guinnes to its board of directors and completing a $127 million private placement of common stock.
Boston Life Sciences is currently evaluating critical data following the early termination of its ALTROPANER POET-1 Phase III trial. The company's commitment to advancing healthcare solutions is evident through its ongoing efforts and strategic growth initiatives.
Generated from the website
Also at this address
See a problem?
Partial Data by Infogroup (c) 2025. All rights reserved.